Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.922
-0.015 (-1.61%)
At close: Jul 6, 2022 4:00 PM
0.940
+0.018 (1.974%)
Pre-market: Jul 7, 2022 4:05 AM EDT

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Year 202020192018
Net Income
-5.05-4.41-4.86
Share-Based Compensation
2.031.80.4
Other Operating Activities
0.30.263.42
Operating Cash Flow
-2.71-2.35-1.05
Acquisitions
0.10.110.23
Investing Cash Flow
0.10.110.23
Share Issuance / Repurchase
2.22.310.24
Debt Issued / Paid
2.25-0.020.07
Financing Cash Flow
4.452.290.31
Net Cash Flow
1.840.05-0.5
Free Cash Flow
-2.71-2.35-1.05
Free Cash Flow Per Share
-0.04-0.03-0.02
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).